Resilience of Precuneus Neurotrophic Signaling Pathways Despite Amyloid Pathology in Prodromal Alzheimer’s Disease

BACKGROUND Reduction of precuneus choline acetyltransferase activity co-occurs with greater beta-amyloid (Aβ) in Alzheimer's disease (AD). Whether this cholinergic deficit is associated with alteration in nerve growth factor (NGF) signaling and its relation to Aβ plaque and neurofibrillary tangle (NFT) pathology during disease onset is unknown. METHODS Precuneus NGF upstream and downstream signaling levels relative to Aβ and NFT pathology were evaluated using biochemistry and histochemistry in 62 subjects with a premortem diagnosis of non-cognitively impaired (NCI; n = 23), mild cognitive impairment (MCI; n = 21), and mild to moderate AD (n = 18). RESULTS Immunoblots revealed increased levels of proNGF in AD subjects but not MCI subjects, whereas cognate receptors were unchanged. There were no significant differences in protein level for the downstream survival kinase-signaling proteins Erk and phospho-Erk among groups. Apoptotic phospho-JNK, phospho-JNK/JNK ratio, and Bcl-2 were significantly elevated in AD subjects. Soluble Aβ1-42 and fibrillar Aβ measured by [(3)H] Pittsburgh compound-B ([(3)H]PiB) binding were significantly higher in AD subjects compared with MCI and NCI subjects. The density of plaques showed a trend to increase, but only 6-CN-PiB-positive plaques reached significance in AD subjects. AT8-positive, TOC-1-positive, and Tau C3-positive NFT densities were unchanged, whereas only AT8-positive neuropil thread density was statistically higher in AD subjects. A negative correlation was found between proNGF, phospho-JNK, and Bcl-2 levels and phospho-JNK/JNK ratio and cognition, whereas proNGF correlated positively with 6-CN-PiB-positive plaques during disease progression. CONCLUSIONS Data indicate that precuneus neurotrophin pathways are resilient to amyloid toxicity during the onset of AD.

[1]  T. Wyss-Coray,et al.  The p75 Neurotrophin Receptor Promotes Amyloid-β(1-42)-Induced Neuritic Dystrophy In Vitro and In Vivo , 2009, The Journal of Neuroscience.

[2]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[3]  Justin L. Vincent,et al.  Disruption of Large-Scale Brain Systems in Advanced Aging , 2007, Neuron.

[4]  M. Masserini,et al.  TrkA pathway activation induced by amyloid-beta (Abeta) , 2009, Molecular and Cellular Neuroscience.

[5]  F. Schmitt,et al.  Synapse stability in the precuneus early in the progression of Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[6]  Stephen W. Scheff,et al.  Mild cognitive impairment: pathology and mechanisms , 2011, Acta Neuropathologica.

[7]  Barbara L. Hempstead,et al.  Regulation of Cell Survival by Secreted Proneurotrophins , 2001, Science.

[8]  E. Mufson,et al.  Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases , 1999, Progress in Neurobiology.

[9]  Ahmad Salehi,et al.  Increased App Expression in a Mouse Model of Down's Syndrome Disrupts NGF Transport and Causes Cholinergic Neuron Degeneration , 2006, Neuron.

[10]  A. Mietelska-Porowska,et al.  The cholinergic system, nerve growth factor and the cytoskeleton , 2011, Behavioural Brain Research.

[11]  T. Cowen,et al.  ProNGF, Sortilin, and Age‐related Neurodegeneration , 2007, Annals of the New York Academy of Sciences.

[12]  Charles D. Smith,et al.  Alzheimer's-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment , 2009, Neuroscience Letters.

[13]  G. Frisoni,et al.  Structural correlates of early and late onset Alzheimer’s disease: voxel based morphometric study , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[14]  B. Gilchrest,et al.  Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. , 1997, The Journal of clinical investigation.

[15]  S. DeKosky,et al.  Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease , 2008, Brain : a journal of neurology.

[16]  A. Levey,et al.  Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (Substantia innominata), and hypothalamus in the rhesus monkey , 1983, The Journal of comparative neurology.

[17]  S. DeKosky,et al.  Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease , 2011, Neurology.

[18]  Benjamin J. Shannon,et al.  Parietal lobe contributions to episodic memory retrieval , 2005, Trends in Cognitive Sciences.

[19]  D. Bredesen,et al.  Selective vulnerability in Alzheimer's disease: Amyloid precursor protein and p75NTR interaction , 2009, Annals of neurology.

[20]  Gregory A. Hickey,et al.  Amyloid-β Antibody Treatment Leads to Rapid Normalization of Plaque-Induced Neuritic Alterations , 2003, The Journal of Neuroscience.

[21]  Philip R. Cohen,et al.  Phosphorylation of microtubule‐associated protein tau by stress‐activated protein kinases , 1997, FEBS letters.

[22]  Barbara L. Hempstead,et al.  Sortilin is essential for proNGF-induced neuronal cell death , 2004, Nature.

[23]  C. Kawas,et al.  Immune reactive cells in senile plaques and cognitive decline in Alzheimer’s disease , 2003, Neurobiology of Aging.

[24]  Martin Klein,et al.  Precuneus atrophy in early-onset Alzheimer’s disease: a morphometric structural MRI study , 2007, Neuroradiology.

[25]  S. Leurgans,et al.  Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease , 2013, Neurobiology of Aging.

[26]  M. Iglesias,et al.  Pro-NGF isolated from the human brain affected by Alzheimer's disease induces neuronal apoptosis mediated by p75NTR. , 2005, The American journal of pathology.

[27]  L. Ferrucci,et al.  Correspondence between in vivo 11C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques , 2012, Acta Neuropathologica.

[28]  Allison Caban-Holt,et al.  University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology. , 2012, Current Alzheimer research.

[29]  J. Wuu,et al.  Increased Matrix Metalloproteinase 9 Activity in Mild Cognitive Impairment , 2009, Journal of neuropathology and experimental neurology.

[30]  Christopher Thrasivoulou,et al.  Neurotoxic and neurotrophic roles of proNGF and the receptor sortilin in the adult and ageing nervous system , 2008, The European journal of neuroscience.

[31]  D. Matusica,et al.  Proteolytic processing of the p75 neurotrophin receptor: A prerequisite for signalling? , 2011, BioEssays : news and reviews in molecular, cellular and developmental biology.

[32]  K. Ishii,et al.  Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of z score images. , 2005, AJNR. American journal of neuroradiology.

[33]  A. Cuello,et al.  Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Leurgans,et al.  Hippocampal ProNGF Signaling Pathways and &bgr;-Amyloid Levels in Mild Cognitive Impairment and Alzheimer Disease , 2012, Journal of neuropathology and experimental neurology.

[35]  Keith A. Johnson,et al.  Functional Alterations in Memory Networks in Early Alzheimer’s Disease , 2010, NeuroMolecular Medicine.

[36]  A. Nebreda,et al.  Reactivating Kinase/p38 Phosphorylates τ Protein In Vitro , 1997 .

[37]  Keith A. Johnson,et al.  Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden , 2011, Alzheimer's & Dementia.

[38]  S. DeKosky,et al.  X-34 labeling of abnormal protein aggregates during the progression of Alzheimer's disease. , 2006, Methods in enzymology.

[39]  A. Cuello,et al.  Amyloid &bgr;-Induced Nerve Growth Factor Dysmetabolism in Alzheimer Disease , 2009, Journal of neuropathology and experimental neurology.

[40]  M. Glucksman,et al.  Characterization of Prefibrillar Tau Oligomers in Vitro and in Alzheimer Disease* , 2011, The Journal of Biological Chemistry.

[41]  S. DeKosky,et al.  Binding of the Positron Emission Tomography Tracer Pittsburgh Compound-B Reflects the Amount of Amyloid-β in Alzheimer's Disease Brain But Not in Transgenic Mouse Brain , 2005, The Journal of Neuroscience.

[42]  G. Beattie,et al.  Biological actions of 53 kDa nerve growth factor as studied by a blot and culture technique , 1989, Neuroscience Letters.

[43]  J. Wuu,et al.  Increased proNGF Levels in Subjects with Mild Cognitive Impairment and Mild Alzheimer Disease , 2004, Journal of neuropathology and experimental neurology.

[44]  J. Schneider,et al.  Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions , 2005, Neurology.

[45]  Hongyan Chen,et al.  Altered Effective Connectivity of the Default Mode Network in Resting-State Amnestic Type Mild Cognitive Impairment , 2013, Journal of the International Neuropsychological Society.

[46]  J. Götz,et al.  Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models , 2004, International Journal of Developmental Neuroscience.

[47]  A. Smith,et al.  Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. , 1995, Dementia.

[48]  E. Mufson,et al.  Nerve growth factor: structure, function and therapeutic implications for Alzheimer's disease. , 2003, Current drug targets. CNS and neurological disorders.

[49]  C. Geula,et al.  Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease. , 2012, The American journal of pathology.

[50]  E. Bigio,et al.  Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease , 2005, Neurobiology of Aging.

[51]  L. Beckett,et al.  Entorhinal Cortex β-Amyloid Load in Individuals with Mild Cognitive Impairment , 1999, Experimental Neurology.

[52]  S. Rombouts,et al.  Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: An fMRI study , 2005, Human brain mapping.

[53]  Steven T. DeKosky,et al.  Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction , 2003, Journal of Chemical Neuroanatomy.

[54]  D. Bennett,et al.  Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. , 1999, Experimental neurology.

[55]  Gina N. LaRossa,et al.  [11C]PIB in a nondemented population , 2006, Neurology.

[56]  J. Ashford,et al.  “Preclinical” AD revisited , 2000, Neurology.

[57]  F. Schmitt,et al.  Alzheimer neuropathologic alterations in aged cognitively normal subjects. , 1999, Journal of neuropathology and experimental neurology.

[58]  G L Shulman,et al.  INAUGURAL ARTICLE by a Recently Elected Academy Member:A default mode of brain function , 2001 .

[59]  Guanhua Yu,et al.  The nerve growth factor precursor proNGF exhibits neurotrophic activity but is less active than mature nerve growth factor , 2004, Journal of neurochemistry.

[60]  S. Wisniewski,et al.  Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment , 2002, Annals of neurology.

[61]  K. Neet,et al.  Biological Activity of Nerve Growth Factor Precursor Is Dependent upon Relative Levels of Its Receptors* , 2009, The Journal of Biological Chemistry.

[62]  J. Wuu,et al.  Progression of tau pathology in cholinergic Basal forebrain neurons in mild cognitive impairment and Alzheimer's disease. , 2011, The American journal of pathology.

[63]  Joanne Wuu,et al.  Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology. , 2003, Journal of Alzheimer's disease : JAD.

[64]  Hiroshi Matsuda,et al.  The role of neuroimaging in mild cognitive impairment , 2007, Neuropathology : official journal of the Japanese Society of Neuropathology.

[65]  J. Lancia,et al.  Tau oligomers and tau toxicity in neurodegenerative disease. , 2012, Biochemical Society transactions.

[66]  J. Wuu,et al.  Reduction of cortical TrkA but not p75NTR protein in early‐stage Alzheimer's disease , 2004, Annals of neurology.

[67]  et al.,et al.  Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET , 2002, NeuroImage.

[68]  Keith A. Johnson,et al.  Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without Dementia , 2009, Neuron.

[69]  Esther B. E. Becker,et al.  Apoptosis Induced by p75NTR Overexpression Requires Jun Kinase-Dependent Phosphorylation of Bad , 2003, The Journal of Neuroscience.

[70]  B. Michalski,et al.  The Precursor Pro-Nerve Growth Factor Is the Predominant Form of Nerve Growth Factor in Brain and Is Increased in Alzheimer's Disease , 2001, Molecular and Cellular Neuroscience.

[71]  I. Ferrer,et al.  Pro-NGF from Alzheimer's disease and normal human brain displays distinctive abilities to induce processing and nuclear translocation of intracellular domain of p75NTR and apoptosis. , 2006, The American journal of pathology.

[72]  D. Schacter,et al.  The Brain's Default Network , 2008, Annals of the New York Academy of Sciences.

[73]  J. Schneider,et al.  Neuropathology of older persons without cognitive impairment from two community-based studies , 2006, Neurology.

[74]  D. Head,et al.  Amyloid Plaques Disrupt Resting State Default Mode Network Connectivity in Cognitively Normal Elderly , 2010, Biological Psychiatry.

[75]  J. Wuu,et al.  Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease , 2006, Journal of neurochemistry.